Evidence map›Paper›PMID 40268239›Full record

ArticleChest2025

Association of Lung Quantitative CT Scan Textures With Systemic Inflammation and Mortality in COPD.

Hira A Awan, Muhammad F A Chaudhary, Anthony D El-Sokkary, Eric A Hoffman, Alejandro P Comellas, Junfeng Guo, Igor Z Barjaktarevic, R Graham Barr, Surya P Bhatt, Sandeep Bodduluri and 14 more

2 registry-linked trialsAbstract read
In one paragraph

Article in Chest, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00608764 active not recruitingnot on this map

Genetic Epidemiology of Chronic Obstructive Pulmonary Disease (COPDGene)

TypeobservationalSponsorBrigham and Women's HospitalRan2007 to 2028Enrolled10,718ConditionsPulmonary Disease, Chronic Obstructive, Emphysema, Bronchitis, Chronic
NCT01969344 active not recruitingnot on this map

Subpopulations and Intermediate Outcome Measures in COPD Study

TypeobservationalSponsorUniversity of North Carolina, Chapel HillRan2010 to 2031Enrolled2,981ConditionsCOPD, Chronic Obstructive Pulmonary Disease, Chronic Bronchitis, Emphysema
3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. The Evolving Landscape of COPD Typization.Medicina (Kaunas, Lithuania) · 2026
    Review
  4. Article
  5. Response.Chest · 2025
    Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

24 authors.

Hira A AwanThe Roy J. Carver Department of Biomedical Engineering, Iowa City, IA.
Muhammad F A ChaudharyThe Roy J. Carver Department of Biomedical Engineering, Iowa City, IA.
Anthony D El-SokkaryRoy J. and Lucille A. Carver College of Medicine, Iowa City, IA.
Eric A HoffmanThe Roy J. Carver Department of Biomedical Engineering, Iowa City, IA; Department of Radiology, Iowa City, IA; Division of Pulmonary, Critical Care and Occupational Medicine, Department of Internal Medicine, University of Iowa, Iowa City, IA.
Alejandro P ComellasDivision of Pulmonary, Critical Care and Occupational Medicine, Department of Internal Medicine, University of Iowa, Iowa City, IA.
Junfeng GuoThe Roy J. Carver Department of Biomedical Engineering, Iowa City, IA; Department of Radiology, Iowa City, IA.
Igor Z BarjaktarevicDivision of Pulmonary and Critical Care Medicine, Los Angeles, CA.
R Graham BarrDepartment of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY.
Surya P BhattCenter for Lung Analytics and Imaging Research, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL.
Sandeep BodduluriCenter for Lung Analytics and Imaging Research, Division of Pulmonary, Allergy and Critical Care Medicine, University of Alabama at Birmingham, Birmingham, AL.
Russell P BowlerGenomic Medicine Institute, Cleveland Clinic Main Campus, Cleveland, OH.
Luis G Vargas BuonfiglioDivision of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, UT.
Christopher B CooperDepartments of Medicine and Physiology, David Geffen School of Medicine at UCLA, Los Angeles, CA.
Ashraf FawzyDivision of Pulmonary and Critical Care Medicine, Johns Hopkins Medicine at Johns Hopkins University, Baltimore, MD.
Annette T HastieSection on Pulmonary, Critical Care, Allergy, and Immunologic Diseases, Department of Internal Medicine, Wake Forest University, School of Medicine, Winston-Salem, NC.
Wassim W LabakiDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI.
Fernando J MartinezDivision of Pulmonary Critical Care Medicine, Weill Cornell Medicine, New York, NY.
Martha G MenchacaDepartment of Radiology, College of Medicine, University of Illinois at Chicago, Chicago, IL.
Wanda O'NealCystic Fibrosis/Pulmonary Research and Treatment Center, University of North Carolina at Chapel Hill, Chapel Hill, NC.
Robert PaineDivision of Respiratory, Critical Care and Occupational Pulmonary Medicine, University of Utah, Salt Lake City, UT.
Joyce D SchroederDepartment of Radiology, Mayo Clinic, Rochester, MN.
Prescott G WoodruffDepartment of Medicine, University of California, San Francisco, San Francisco, CA.
Jeffrey L CurtisDivision of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI; Medical Service, VA Ann Arbor Healthcare System, Ann Arbor, MI.
Joseph M ReinhardtThe Roy J. Carver Department of Biomedical Engineering, Iowa City, IA; Department of Radiology, Iowa City, IA. Electronic address: joe-reinhardt@uiowa.edu.

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Jon C.D. Houtman · 2000 to 2026
$70.0M
Genetic Epidemiology of COPDU01HL089897 · NHLBI · NATIONAL JEWISH HEALTH · PI CRAPO, JAMES D · 2007 to 2021
$56.9M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
GENETIC EPIDEMIOLOGY OF COPD (COPD GENE) TASK A: STUDY VISIT 4, COLLECTION OF COPDGENE STUDY DATA ANDBIOSPECIMENS AND OVERSIGHT OF THE COPDGENE STUDY75N92023D00011 · NHLBI · NATIONAL JEWISH HEALTH · PI NEWMAN, LEE S · 2023 to 2025
$29.6M
SPIROMICS II: Biological underpinnings of COPD heterogeneity and progressionU01HL137880 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WOODRUFF, PRESCOTT G · 2017 to 2021
$27.9M
Genetic Epidemiology of COPDU01HL089856 · NHLBI · BRIGHAM AND WOMEN'S HOSPITAL · PI SILVERMAN, EDWIN K · 2007 to 2021
$20.7M
SPIROMICS GIC SupportU24HL141762 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI COUPER, DAVID J, O'NEAL, WANDA K · 2018 to 2022
$7.2M
Multi-center Structural & Functional Quantitative CT Pulmonary PhenotypingR01HL112986 · NHLBI · UNIVERSITY OF IOWA · PI HOFFMAN, ERIC ALFRED · 2012 to 2016
$4.6M
Biomarker of Lung Disease in African AmericansR01HL137995 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL, KECHRIS-MAYS, KATHERINA · 2018 to 2021
$3.4M
Lung Biomechanics and Disease Progression in SPIROMICSR01HL142625 · NHLBI · UNIVERSITY OF IOWA · PI REINHARDT, JOSEPH M · 2018 to 2021
$2.2M
Ultra-low Dose, High Speed, High Resolution, Multispectral, Multi-Source MDCT ScaS10OD018526 · OD · UNIVERSITY OF IOWA · PI HOFFMAN, ERIC ALFRED · 2015 to 2015
$2.0M
Sphingolipids and inflammatory biomarkers of COPD progression in healthy smokersR01HL129937 · NHLBI · NATIONAL JEWISH HEALTH · PI BOWLER, RUSSELL PAUL · 2015 to 2017
$1.3M
NCI NIH HHS P30 CA086862NHLBI NIH HHS 75N92023D00011NHLBI NIH HHS HHSN268200900013CNHLBI NIH HHS HHSN268200900014CNHLBI NIH HHS HHSN268200900015CNHLBI NIH HHS HHSN268200900016CNHLBI NIH HHS HHSN268200900017CNHLBI NIH HHS HHSN268200900018CNHLBI NIH HHS HHSN268200900020CNHLBI NIH HHS R01 HL112986NHLBI NIH HHS R01 HL129937NHLBI NIH HHS R01 HL137995NHLBI NIH HHS R01 HL142625NHLBI NIH HHS U01 HL089856NHLBI NIH HHS U01 HL089897NHLBI NIH HHS U01 HL137880NHLBI NIH HHS U24 HL141762NIEHS NIH HHS P30 ES005605NIH HHS S10 OD018526
6 · The paper itself

Abstract

backgroundCOPD is characterized by persistent inflammation that is responsible for remodeling the bronchovascular bundles (BVBs), which may lead to poor quality of life. Quantitative CT (QCT) scan textures of the lung can capture local disease patterns of inflammation and related respiratory morbidity. RESEARCH QUESTION: Are BVB textures, obtained from the adaptive multiple feature method, associated with systemic inflammation, morbidity, and mortality in COPD? STUDY DESIGN AND

methodsWe analyzed data from the Subpopulations and Intermediate Outcome Measures in COPD Study (SPIROMICS; n = 2,981) and the Genetic Epidemiology of COPD (COPDGene) study (n = 10,305). The predictors included 2 QCT scan biomarkers, the BVB and CT density gradient (CTDG) textures, age, sex, BMI, race, smoking status, pack-years of smoking, CT scan-detected emphysema, and square root of the wall area of a hypothetical airway with a 10-mm lumen perimeter (Pi10). Outcomes included plasma biomarker concentrations from Meso Scale Discovery proteomics assays and CBC counts, both as markers of inflammation, along with FEV

resultsIncreased BVB texture was associated significantly with elevated neutrophil and monocyte counts and the neutrophil to lymphocyte ratio, independent of clinical covariates, CT scan-detected emphysema, and Pi10. Elevated CTDG was associated with increased neutrophil count, NLR, and tumor necrosis factor α. Increased CTDG and BVB textures also were associated with a lower FEV

interpretationQCT scan textures may provide imaging evidence of the spatial heterogeneity of lung inflammation and overall disease burden in COPD. CLINICAL

trial registrationClinicalTrials.gov; Nos.: NCT01969344 (SPIROMICS) and NCT00608764 (COPDGene); URL: www. CLINICALTRIALS: gov.

Indexed as

InflammationLungPulmonary Disease, Chronic ObstructiveTomography, X-Ray ComputedAgedBiomarkersFemaleForced Expiratory VolumeHumansMaleMiddle AgedBiomarkersbronchovascular bundles textureCOPDCT density gradient texturelung function declinemortalityquantitative CT scan texturessystemic inflammation

Identifiers

PMID40268239
PMCPMC12410363

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.